Richard K Prins is of Amphastar Pharmaceuticals, Inc.. Currently has a direct ownership of 30,061 shares of AMPH, which is worth approximately $1.1 Million. The most recent transaction as insider was on Dec 09, 2024, when has been sold 10,000 shares (Common Stock) at a price of $43.77 per share, resulting in proceeds of $437,700. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 30.1K
11.51% 3M change
2.7% 12M change
Total Value Held $1.1 Million

RICHARD K PRINS Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 09 2024
SELL
Open market or private sale
$437,700 $43.77 p/Share
10,000 Reduced 24.71%
30,471 Common Stock
Dec 09 2024
SELL
Bona fide gift
-
410 Reduced 1.35%
30,061 Common Stock
Dec 09 2024
BUY
Exercise of conversion of derivative security
$195,200 $19.52 p/Share
10,000 Added 19.81%
40,471 Common Stock
Nov 12 2024
SELL
Bona fide gift
-
1,000 Reduced 3.18%
30,471 Common Stock
Nov 12 2024
SELL
Open market or private sale
$244,000 $48.8 p/Share
5,000 Reduced 13.71%
31,471 Common Stock
Nov 12 2024
BUY
Exercise of conversion of derivative security
$41,725 $16.69 p/Share
2,500 Added 6.42%
36,471 Common Stock
Aug 12 2024
SELL
Open market or private sale
$736,540 $43.07 p/Share
17,101 Reduced 33.48%
33,971 Common Stock
Aug 12 2024
BUY
Exercise of conversion of derivative security
$339,967 $19.88 p/Share
17,101 Added 25.08%
51,072 Common Stock
Jun 03 2024
BUY
Grant, award, or other acquisition
-
3,076 Added 8.3%
33,971 Common Stock
Nov 17 2023
SELL
Bona fide gift
-
1,000 Reduced 3.14%
30,895 Common Stock
Nov 17 2023
SELL
Open market or private sale
$223,440 $55.86 p/Share
4,000 Reduced 11.14%
31,895 Common Stock
Nov 13 2023
SELL
Open market or private sale
$262,500 $52.5 p/Share
5,000 Reduced 12.23%
35,895 Common Stock
Aug 18 2023
SELL
Open market or private sale
$105,000 $52.5 p/Share
2,000 Reduced 4.66%
40,895 Common Stock
Aug 15 2023
SELL
Open market or private sale
$238,914 $57.39 p/Share
4,163 Reduced 8.85%
42,895 Common Stock
Jun 05 2023
BUY
Grant, award, or other acquisition
-
2,716 Added 5.46%
47,058 Common Stock
May 15 2023
SELL
Open market or private sale
$217,500 $43.5 p/Share
5,000 Reduced 10.13%
44,342 Common Stock
May 15 2023
BUY
Exercise of conversion of derivative security
$83,450 $16.69 p/Share
5,000 Added 9.2%
49,342 Common Stock
May 12 2023
SELL
Open market or private sale
$210,300 $42.06 p/Share
5,000 Reduced 9.55%
47,342 Common Stock
May 12 2023
SELL
Bona fide gift
-
3,000 Reduced 6.34%
44,342 Common Stock
May 12 2023
BUY
Exercise of conversion of derivative security
$83,450 $16.69 p/Share
5,000 Added 8.72%
52,342 Common Stock
Jun 10 2022
BUY
Grant, award, or other acquisition
-
4,163 Added 8.08%
47,342 Common Stock
May 17 2022
SELL
Bona fide gift
-
2,000 Reduced 4.43%
43,179 Common Stock
Mar 15 2022
SELL
Open market or private sale
$340,200 $34.02 p/Share
10,000 Reduced 18.12%
45,179 Common Stock
Mar 15 2022
BUY
Exercise of conversion of derivative security
$171,100 $17.11 p/Share
10,000 Added 15.34%
55,179 Common Stock
Dec 10 2021
SELL
Open market or private sale
$113,016 $21.36 p/Share
5,291 Reduced 10.48%
45,179 Common Stock

Also insider at

IGC
India Globalization Capital, Inc. Industrials
RKP

Richard K Prins

Rancho Cucamonga,, CA

Track Institutional and Insider Activities on AMPH

Follow Amphastar Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AMPH shares.

Notify only if

Insider Trading

Get notified when an Amphastar Pharmaceuticals, Inc. insider buys or sells AMPH shares.

Notify only if

News

Receive news related to Amphastar Pharmaceuticals, Inc.

Track Activities on AMPH